EMA approves Sanofi’s treatment for obstructive pulmonary disease
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.
Drugs
Health
Pharma
Drugs
Health
Pharma
EMA expands probe into suicidal thoughts linked to weight loss drugs
HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist.
Drugs
Health
Pharma
FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns
HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug.
Drugs
Medical
Pharma
Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Medical
Pharma
Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs
Pharma
Sanofi signs $1.2 billion drug discovery agreement with Insilico
Sanofi signs $1.2 billion drug discovery deal with AI driven drug startup Insilico